# Shukra Pharmaceuticals Ltd (SHUKRAPHAR)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹31.4
Day Change: -2.61%
52W High: ₹65.26
52W Low: ₹12.75
Market Cap: ₹1,375 Cr

## Valuation
P/E: 62.8
P/B: 22.69
EPS: ₹0.5
Book Value: ₹1.38
Dividend Yield: 3%

## Returns
1Y Return: 147.44%

## Profitability
ROE: 17.24%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Shukra Pharmaceuticals Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Shukra Pharmaceuticals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement: Announcement under Regulation 30 (LODR)-Allotment
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Data Freshness
Quote Updated: 2026-05-16T23:56:24.992Z
Price History Updated: 2026-05-18T22:59:03.850Z
Latest Price History Date: 2026-05-15
Technicals Updated: 2026-05-18T22:59:03.850Z
Quant Updated: 2026-05-18T22:59:03.850Z
Sentiment Updated: 2026-05-18T22:59:03.850Z
Financials Status: current
Financials Updated: 2026-05-18T10:30:01.379Z
Financials Last Attempt: 2026-05-18T10:30:01.379Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2026)
Revenue: ₹33 Cr
Operating Profit: ₹13 Cr (OPM 39%)
Net Profit: ₹10 Cr
Tax: ₹13 Cr

## Balance Sheet (Mar 2026)
Total Assets: ₹87 Cr
Total Liabilities: ₹87 Cr
Borrowings: ₹4 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/shukraphar
Disclaimer: For research and education only. Not investment advice.